Yonjin Capital
Overview
Yonjin Capital LLC is the North America and Europe investment arm of Yongjin Group and the sister firm of Yonghua Capital, both based in China with headquarters in Shanghai. Yonjin Venture LLC specializes in early- and mid-stage life science companies. We are interested in innovative technologies in therapeutics, diagnostics and medical devices.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| HistoSonics | Aug 2025 | Buyout/LBO | Co-investor |
| Rapafusyn Pharmaceuticals | Sep 2025 | Series A | Lead |
| TECLens, Inc. | Feb 2025 | Series A | Lead |
| EvolveImmune Therapeutics | Jan 2020 | Series A | Lead |
| Spear Bio | Jul 2024 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Yonjin Capital based?
Yonjin Capital is headquartered in Cambridge, Massachusetts, United States.
When was Yonjin Capital founded?
Yonjin Capital was founded in 1995.
How many portfolio companies does Yonjin Capital have?
Yonjin Capital has 11 portfolio companies in Caplight's dataset.
What are some companies in Yonjin Capital's portfolio?
Portfolio companies visible on Caplight include HistoSonics, Rapafusyn Pharmaceuticals, TECLens, Inc., EvolveImmune Therapeutics, Spear Bio.
What was Yonjin Capital's most recent investment shown here?
Yonjin Capital's most recent investment in this portfolio sample was in Rapafusyn Pharmaceuticals in 2025.
What sectors does Yonjin Capital focus on?
Yonjin Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software.
What company stages does Yonjin Capital focus on?
Yonjin Capital typically invests at the MultiStage stage.
What is Yonjin Capital's AUM?
Yonjin Capital's assets under management are estimated between $100.0M and $250.0M.